Personalised medicine produced in a “Bionexpresso” - News - Utrecht University
Cv huub schellekens complet by Ricardo Guerrero - Issuu
EMJ Oncology 6 [Suppl 2] 2018 - European Medical Journal
WORKSHOP
eLearning – Biosimilars: From concern to confidence
Huub Schellekens – Studium Generale Universiteit Utrecht
Huub Schellekens's research works | Utrecht University, Utrecht (UU) and other places
Huub Schellekens's research works | Utrecht University, Utrecht (UU) and other places
Zomerportret 1. Huub Schellekens: 'Iedereen moet weer gaan doen waar hij goed in is' | medischcontact
The First Biosimilar Epoetin: But How Similar Is It?
eLearning module: Clinical development – Biosimilars: From concern to confidence
Huub Schellekens | Writers Unlimited
Clinical comparability and European biosimilar regulations
Immunogenicity and aggregation of therapeutic proteins - American ...
Huub Schellekens's research works | Utrecht University, Utrecht (UU) and other places
Schellekens, Huub | European Association of Hospital Pharmacists
Huub Schellekens's research works | Utrecht University, Utrecht (UU) and other places
Huub Schellekens | Writers Unlimited
Development of <fc>ADA</fc> Against Recombinant Human Interferon Beta in Immune Tolerant Mice Requires Rapid Recruit
Zomerportret 1. Huub Schellekens: 'Iedereen moet weer gaan doen waar hij goed in is' | medischcontact
Immunogenicity of Recombinant Human Interferon Beta Interacting with Particles of Glass, Metal, and Polystyrene
Development of a Transgenic Mouse Model to Study the Immunogenicity of Recombinant Human Insulin
Efficacy and Safety of Orally/Sublingually, Intranasally, and Intraperitoneally Administered Recombinant Murine Interferon in th
Huub Schellekens's research works | Utrecht University, Utrecht (UU) and other places
Biosimilar therapeutics—what do we need to consider?
PDF) Differences Between Post-Authorization Adverse Drug Reactions of Biopharmaceuticals and Small Molecules | Ellen Moors - Academia.edu
